Orthopedic Biomaterials
Orthopedic Biomaterials
The orthopedic biomaterials market includes bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid viscosupplementation, cartilage repair and machined bone allografts. The orthopedic biomaterials market consists of materials that are organic, inorganic or synthetic in nature. These materials are implanted or applied in or near the indicated bone to facilitate healing, encourage bone tissue augmentation, compensate in areas where bone tissue is depleted and restore structure to allow for repair.
“I was impressed with the depth and breadth of information contained in the report.”
-Jordan Fein, Marketing Research Analyst
Zimmer Biomet N
Zimmer Biomet N
“The reports are very useful”
-R&D Team Leader
Medinol
Medinol
“Great overall experience with iData Research as a company. The type of research they provide should be part of all new product development efforts.”
-Laszlo Garamszegi, CTO
Aurora Spine
Aurora Spine
“iData provides the best-detailed level analysis for segments and sub-segments of any industry reports available.”
-Medical Device Commercialization Strategist
The Experia Group, LLC
The Experia Group, LLC
“Great products, outstanding customer service.”
-Manager
Zeus Industrial Products, Inc.
Zeus Industrial Products, Inc.
“Most complete data available. Very flexible in providing only the things I needed.”
-Orthopedic Surgeon
Chattanooga Orthopedic Group
Chattanooga Orthopedic Group
iData Research has an ever-expanding medical market intelligence library consisting of focused, in-depth, accurate, and exclusive research you will not find anywhere else. Our highly qualified team of industry analysts follow a structured and independent research methodology designed to provide the most valuable return on actionable market data in the world.
Showing all 2 results
-
Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite
Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite
The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market. The Asia-Pacific orthopedic biomaterials report covers the... more... -
Bone Graft Substitutes and Other Biomaterials Market Report Suite |Australia, Japan, South Korea | 2009-2015 | MedSuite
Bone Graft Substitutes and Other Biomaterials Market Report Suite |Australia, Japan, South Korea | 2009-2015 | MedSuite
The Asia-Pacific market includes Japan, South Korea, and Australia. In 2008, the combined Asia-Pacific market for dental bone graft substitutes (BGS) and other biomaterials was valued at nearly US$62.5 million. The economic recession, beginning in 2008, led to a decline in the unit growth ate of... more...
